STRATIFICATION OF HIGH-RISK PROSTATE CANCER INTO PROGNOSTIC CATEGORIES; A EUROPEAN MULTI-INSTITUTIONAL STUDY

被引：0
|
作者：
Joniau, Steven
Gontero, Paolo
Briganti, Alberto
Fieuws, Steffen
Tombal, Bertrand
Marchioro, Giansilvio
Hsu, Chao-Yu
Frea, Bruno
Montorsi, Francesco
Van Poppel, Hein
Spahn, Martin
机构：
来源：
JOURNAL OF UROLOGY | 2012年 / 187卷 / 04期
关键词：
D O I：
10.1016/j.juro.2012.02.425
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
363
引用
收藏
页码：E148 / E149
页数：2
相关论文
共 50 条
  • [31] Sunitinib plus hormone ablation and radiation therapy for patients with high-risk localized prostate cancer: Results from a multi-institutional phase I study
    Corn, Paul G.
    Song, Danny
    Heath, Elisabeth
    Maier, Jordan
    Meyn, Raymond
    Kuban, Deborah
    DiPetrillo, Thomas
    Mathew, Paul
    CANCER RESEARCH, 2012, 72
  • [32] Sunitinib Plus Androgen Deprivation and Radiation Therapy for Patients With Localized High-Risk Prostate Cancer: Results From a Multi-institutional Phase 1 Study
    Corn, Paul G.
    Song, Danny Y.
    Heath, Elisabeth
    Maier, Jordan
    Meyn, Raymond
    Kuban, Deborah
    DePetrillo, Thomas A.
    Mathew, Paul
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (03): : 540 - 545
  • [33] Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database
    Hervas, A.
    Pastor, J.
    Gonzalez, C.
    Jove, J.
    Gomez, A.
    Casana, M.
    Villafranca, E.
    Mengual, J. L.
    Munoz, V.
    Henriquez, I.
    Munoz, J.
    Collado, E.
    Clemente, J.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2019, 21 (07): : 900 - 909
  • [34] Predicting high-risk prostate cancer—a novel stratification tool
    Jessica Buck
    Bilal Chughtai
    Nature Reviews Urology, 2014, 11 : 256 - 257
  • [35] Adjusted Intermediate and High-Risk Stratification for Prostate Cancer Is More Prognostic Than Current NCCN Risk Grouping
    Liu, J. T.
    Ko, E. C.
    Kerns, S. L.
    Stone, N. N.
    Stock, R. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S383 - S383
  • [36] Outcomes and prognostic factors in intermediate-risk prostate cancer: multi-institutional analysis of the Spanish RECAP database
    A. Hervás
    J. Pastor
    C. González
    J. Jové
    A. Gómez
    M. Casaña
    E. Villafranca
    J. L. Mengual
    V. Muñoz
    I. Henriquez
    J. Muñoz
    E. Collado
    J. Clemente
    Clinical and Translational Oncology, 2019, 21 : 900 - 909
  • [37] PROSTATE CANCER Predicting high-risk prostate cancer-a novel stratification tool
    Buck, Jessica
    Chughtai, Bilal
    NATURE REVIEWS UROLOGY, 2014, 11 (05) : 256 - 257
  • [38] Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study
    Baykal, Kadir
    Soydan, Hasan
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2007, 6 (02): : 33 - 35
  • [39] Stereotactic body radiotherapy boost toxicity for high and intermediate-risk prostate cancer: Report of a multi-institutional study
    Kaplan, Irving D.
    Appelbaum, Limor
    Aghdam, Nima
    Martin, Jarad
    Sidhom, Mark
    Pryor, David
    Aronovitz, Joseph A.
    Mahadevan, Anand
    Kennedy, Kevin F.
    Collins, Sean P.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [40] Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: A multi-institutional pilot study
    Kibel, Adam S.
    Rosenbaum, Eli
    Kattan, Michael W.
    Picus, Joel
    Dreicer, Robert
    Klein, Eric A.
    Chatta, Gurkamal S.
    Nelson, Joel B.
    DiPaola, Robert S.
    Roth, Bruce J.
    Cookson, Michael S.
    Wilding, George
    Jarrard, David F.
    Beer, Tomasz M.
    Ryan, Christopher W.
    Petrylak, Daniel P.
    Benson, Mitchell C.
    Partin, Alan W.
    Garrett-Mayer, Elizabeth
    Eisenberger, Mario A.
    JOURNAL OF UROLOGY, 2007, 177 (05): : 1777 - 1781
12345